WRX606 is an orally active nonrapalog inhibitor for mTOR complex 1 ( mTORC1M ). WRX606 inhibits the phosphorylation of mTORC1 substrate S6 kinase 1 ( S6K1 ) ( IC 50 = 10 nM) and eukaryotic translation initiation factor 4E binding protein (p-4E-BP1) ( IC 50 = 0.27 μM) in MCF-7 cells. WRX606 suppresses tumor growth in mice without promotion of metastasis. WRX606 can be studied in research as an antitumor agent.
Products | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > mTOR
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.